Search
Sophia Genetics SA
SOPHAdd to Watchlist
6.180USD
+0.130+2.15%
Close 07-23 16:00（ET）Quotes delayed by 15 min
443.66MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Sophia Genetics SA is 9.00, ranking 6 out of 485 in the Software & IT Services industry. The average price target is 7.00, with a high of 9.00 and a low of 6.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
9.000
Target Price
+38.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Sophia Genetics SA
SOPH
5
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sophia Genetics SA's expected revenue for the next quarter?
Sophia Genetics SA's expected revenue is 21.73M.
What is Sophia Genetics SA's price target?
Analysts forecast that Sophia Genetics SA's price target is USD 7.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 6.00.
How have Sophia Genetics SASOPH's recent earnings per share performed?
The market expectation was USD -0.27, while Sophia Genetics SASOPH's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.21.
What is the analyst rating for Sophia Genetics SA?
Based on the ratings of Sophia Genetics SA's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.